Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tumor samples from HCC patients receiving Nivolumab THP-1 cells under different stimulas.

ABSTRACT: Tumor samples from HCC patients receiving Nivolumab THP-1 cells under different stimulas.

PROVIDER: PRJNA890644 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21837846_1.fastq.gz	Fastqsanger.gz
	SRR21837846_2.fastq.gz	Fastqsanger.gz
	SRR21837847_1.fastq.gz	Fastqsanger.gz
	SRR21837847_2.fastq.gz	Fastqsanger.gz
	SRR21837848_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 36

Similar Datasets

Expression data from patients with HCC receiving Nivolumab

Project description:We have generated an immune classifier able to identify patients belonging to the immune subclass of HCC. Characteristics of the immune subclass resemble those of patients who most respond to immunotherapy. We performed microarray expression of the tumors of two patients before starting treatment with nivolumab to verify if the immune classifier generated was able to predict response to immunotherapy.

2018-01-31 | GSE93647 | GEO

Next Generation Sequencing Facilitates Quantitative Analysis of tumor samples from HCC patients receiving Nivolumab.

Project description:To identify critical tumor-secreting factors that may contribute to immunotherapy efficacy against HCC, we subjected tumor samples from 10 HCC patients to whole-transcriptome sequencing, and categorized the patients into two groups according to clinical response to nivolumab. We then performed gene expression profiling analysis using data obtained from RNA-seq of Nivolumab reponders and non-reponsers.

2023-12-06 | GSE215011 | GEO

Tumor samples from HCC patients receiving Nivolumab; THP-1 cells under different stimulas.

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-12-06 | GSE215013 | GEO

Next Generation Sequencing Facilitates Quantitative Analysis of tumor samples from HCC patients receiving Nivolumab.

Project description:Next Generation Sequencing Facilitates Quantitative Analysis of tumor samples from HCC patients receiving Nivolumab.

| PRJNA906102 | ENA

Next Generation Sequencing Facilitates Quantitative Analysis of THP-1 cells under different stimulas.

Project description:To explore the role of human RNase1 on macrophage polarization, we induced human monocytes (THP-1) to differentiate into uncommitted macrophages and then polarized them to different phenotypes by lipopolysaccharide (LPS)/interferon (IFN)-γ, interleukin (IL)-4, or RNase1 as a stimulus. We then performed gene expression profiling analysis using data obtained from RNA-seq of Nivolumab reponders and non-reponsers.

2023-12-06 | GSE215012 | GEO

RNA-seq of THP-1 cells and tumor-associated macrophages sorted from HCC tumor tissues.

Project description:RNA-seq of THP-1 cells and tumor-associated macrophages sorted from HCC tumor tissues.

2021-03-16 | GSE168922 | GEO

Differentiation of cultured THP-1 cells

Project description:Libraries constructed from cultured THP-1 cells receiving PMA treatment or not. Keywords: other

2004-11-19 | GSE1439 | GEO

Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC

Project description:This is a single arm phase II study of adjuvant intra-dermal NA DC vaccine combined with intravenous nivolumab in patients with resectable HCC (group A) or CRLM (group B) planned for curative surgery (with/without local ablation).

| 2379524 | ecrin-mdr-crc

Differentiation of cultured THP-1 cells

Project description:Libraries constructed from cultured THP-1 cells receiving PMA treatment or not. Keywords: other

2004-11-18 | E-GEOD-1439 | biostudies-arrayexpress

Homo sapiens

Project description:Expression data from patients with HCC receiving Nivolumab

| PRJNA361457 | ENA